Discovery of highly potent SARS-CoV-2 Mpro inhibitors based on benzoisothiazolone scaffold-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of highly potent SARS-CoV-2 Mpro inhibitors based on benzoisothiazolone scaffold

Published:2022-02 Issue: Volume:58 Page:128526
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Chen Weixiong,Feng Bo,Han Sheng,Wang Peipei,Chen Wuhong,Zang Yi,Li Jia,Hu Youhong

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference32 articles.

1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

2. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2;Kalita;Microb Pathog,2020

3. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med,2021

5. Delta variant triggers new phase in the pandemic;Kupferschmidt;Science,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11

2. Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives;Biomolecules;2023-09-02

3. Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group;Journal of Medicinal Chemistry;2023-08-18

4. Cyclic Sulfinamides;The Chemical Record;2023-08-18

5. Bioinformatic assay reveal the potential mechanism of Guizhi-Shaoyao-Zhimu decoction against rheumatoid arthritis and mild-to-moderate COVID-19;Computer Methods and Programs in Biomedicine;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3